Positron Emission Tomography Study Using 2-[18F]-F-A85380 to Determine α4β2 Neuronal Nicotinic Receptor Occupancy of AZD3480 After Oral Administration to Healthy Male Subjects (PET)
This study has been completed.
Study NCT00686413
Information provided by AstraZeneca
First Received on May 27, 2008.
Last Updated on December 8, 2010
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study: